Fact sheet: Parvest EqWdHthCre

Fund information

Fund name
Parvest Equity World Health Care Classic Cap EUR
Fund company manager
BNP Paribas Asset Management L
Fund type
SIB
Fund manager
Jon Stephenson
since 02/05/2016
Fund objective
Increase the value of its assets over the medium term.
Benchmark
MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

0.51 %

1 Year rank in sector

23/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 323.4 m

FE Risk score

148

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    74.4%
  • UK
    8.8%
  • Switzerland
    8.18%
  • Germany
    6%
  • Japan
    2.11%
  • Pharmaceuticals
    46.18%
  • Biotechnology/Medical
    23.48%
  • Health Care
    15.64%
  • Healthcare & Medical Products
    14.7%
  • US Equities
    74.4%
  • UK Equities
    8.8%
  • Swiss Equities
    8.18%
  • German Equities
    6%
  • Japanese Equities
    2.11%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-4.26 %-4.43 %0.51 %28.89 %85.72 %
Sector-2.14 %3.95 %6.57 %24.27 %99.62 %
Rank within sector28 / 3026 / 2923 / 299 / 2616 / 23
Quartile th4 th4 th4 th2 nd3 rd

Calendar performance

YTD-20172016201520142013
Fund1.72 %-8.75 %15.07 %34.91 %31.67 %
Sector12.56 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector25 / 2913 / 295 / 2710 / 2418 / 23
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha1.26
Beta1.04
Sharpe0.35
Volatility17.81
Tracking error7.55
Information ratio0.17
R-Squared0.82

Price movement

52 week high995.53
52 week low804.23
Current bid price0
Current offer price0
Current mid price907.8

Holdings by region

  • 74.4% USA
  • 8.8% UK
  • 8.18% Switzerland
  • 6% Germany
  • 2.11% Japan
  • 0.51% Ireland

Holdings by sector

  • 46.18% Pharmaceuticals
  • 23.48% Biotechnology/Medical
  • 15.64% Health Care
  • 14.7% Healthcare & Medical Products

Holdings by asset type

  • 74.4% US Equities
  • 8.8% UK Equities
  • 8.18% Swiss Equities
  • 6% German Equities
  • 2.11% Japanese Equities
  • 0.51% Irish Equities

Individual holdings

  • 7.25% UNITEDHEALTH GROUP INC
  • 6.07% CELGENE CORP
  • 5.82% ALLERGAN INC
  • 5.69% MERCK & CO INC(NEW)
  • 4.52% LILLY (ELI) & CO
  • 4.29% JAZZ PHARMACEUTICALS PLC
  • 4.08% BOSTON SCIENTIFIC CORP
  • 4.02% EDWARDS LIFESCIENCES CORP
  • 3.95% NOVARTIS AG
  • 3.34% ROCHE HLDG AG